• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图评估早期心脏淀粉样变性的自然病史和疾病进展。

Natural History and Disease Progression of Early Cardiac Amyloidosis Evaluated by Echocardiography.

机构信息

Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Am J Cardiol. 2020 Oct 15;133:126-133. doi: 10.1016/j.amjcard.2020.07.050. Epub 2020 Jul 28.

DOI:10.1016/j.amjcard.2020.07.050
PMID:32811652
Abstract

Since the diagnosis of cardiac amyloidosis (CA) is often delayed, echocardiographic findings are frequently indicative of advanced cardiomyopathy. We aimed to describe early echocardiographic features in patients subsequently diagnosed with CA. Preamyloid diagnosis echocardiographic studies were screened for structural and functional parameters and stratified according to the pathogenetic subtype (immunoglobulin light-chain [AL] or amyloid transthyretin [ATTR]). Abnormalities were defined based on published guidelines. Our cohort included 75 CA patients of whom 42 (56%) were diagnosed with AL and 33 (44%) with ATTR. Forty-two patients had an earlier echocardiography exam available for review. Patients presented with increased wall thickness (1.3 [interquartile range {IQR} 1.0, 1.5] cm) ≥3 years before the diagnosis of CA and relative wall thickness was increased (0.47 [IQR 0.41, 0.50]) ≥7 years prediagnosis. One to 3 years before CA diagnosis restrictive left ventricular (LV) filling pattern was present in 19% of patients and LV ejection fraction ≤50% was present in 21% of patients. Right ventricular dysfunction was detected concomitantly with disease diagnosis. The echocardiographic phenotype of ATTR versus AL-CA showed increased relative wall thickness (0.74 [IQR 0.62, 0.92] versus 0.62 [IQR 0.54, 0.76], p = 0.004) and LV mass index (144 [IQR 129, 191] versus 115 [IQR 105, 146] g/m, p = 0.020) and reduced LV ejection fraction (50 [IQR 44, 58] versus (60 [IQR 53, 60]%, p = 0.009) throughout the time course of CA progression, albeit survival time was similar. In conclusion, increased wall thickness and diastolic dysfunction in CA develop over a time course of several years and can be diagnosed in their earlier stages by standard echocardiography.

摘要

由于心脏淀粉样变性(CA)的诊断常常被延误,因此超声心动图的发现常常提示晚期心肌病。我们旨在描述随后被诊断为 CA 的患者的早期超声心动图特征。筛选了前淀粉样变诊断的超声心动图研究,以评估结构和功能参数,并根据致病亚型(免疫球蛋白轻链[AL]或淀粉样转甲状腺素[ATTR])进行分层。根据已发表的指南定义异常。我们的队列包括 75 名 CA 患者,其中 42 名(56%)被诊断为 AL,33 名(44%)为 ATTR。42 名患者有可供复查的早期超声心动图检查。患者在 CA 诊断前 3 年以上出现壁增厚(1.3[四分位距{IQR}1.0,1.5]cm)和相对壁厚度增加(0.47[IQR 0.41,0.50])≥7 年。在 CA 诊断前 1 至 3 年,19%的患者出现限制性左心室(LV)充盈模式,21%的患者出现 LV 射血分数≤50%。同时发现右心室功能障碍。ATTR 与 AL-CA 的超声心动图表型显示相对壁厚度增加(0.74[IQR 0.62,0.92]与 0.62[IQR 0.54,0.76],p=0.004)和 LV 质量指数增加(144[IQR 129,191]与 115[IQR 105,146]g/m,p=0.020)和 LV 射血分数降低(50[IQR 44,58]与(60[IQR 53,60]%,p=0.009)贯穿 CA 进展的整个过程,尽管生存时间相似。总之,CA 中的壁增厚和舒张功能障碍在数年内发展,可以通过标准超声心动图在早期阶段诊断。

相似文献

1
Natural History and Disease Progression of Early Cardiac Amyloidosis Evaluated by Echocardiography.超声心动图评估早期心脏淀粉样变性的自然病史和疾病进展。
Am J Cardiol. 2020 Oct 15;133:126-133. doi: 10.1016/j.amjcard.2020.07.050. Epub 2020 Jul 28.
2
Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.轻链型与转甲状腺素蛋白心脏淀粉样变性患者特征和当代心脏结局的差异。
PLoS One. 2021 Aug 9;16(8):e0255487. doi: 10.1371/journal.pone.0255487. eCollection 2021.
3
Right Ventricular Strain Improves the Echocardiographic Diagnosis and Risk Stratification of Transthyretin Cardiac Amyloidosis Among Other Phenotypes of Left Ventricular Hypertrophy.右室应变提高了超声心动图对转甲状腺素蛋白心脏淀粉样变的诊断和危险分层,而转甲状腺素蛋白心脏淀粉样变属于左心室肥厚的其他表型。
J Am Soc Echocardiogr. 2024 Oct;37(10):947-959. doi: 10.1016/j.echo.2024.06.006. Epub 2024 Jun 26.
4
Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.左心房应变成像可区分心脏淀粉样变性和高血压性心脏病。
Int J Cardiovasc Imaging. 2021 Jan;37(1):81-90. doi: 10.1007/s10554-020-01948-9. Epub 2020 Jul 29.
5
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.转甲状腺素相关与轻链心脏淀粉样变性的左心室结构和功能。
Circulation. 2014 May 6;129(18):1840-9. doi: 10.1161/CIRCULATIONAHA.113.006242. Epub 2014 Feb 21.
6
Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.心脏淀粉样变中心房颤动和心房颤动亚型:临床和超声心动图特征及其对死亡率的影响。
Amyloid. 2019 Sep;26(3):128-138. doi: 10.1080/13506129.2019.1620724. Epub 2019 Jun 7.
7
Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis.二维超声心动图测量右心室应变在心脏淀粉样变性诊断中的作用。
J Am Soc Echocardiogr. 2019 Jul;32(7):845-853.e1. doi: 10.1016/j.echo.2019.03.005. Epub 2019 May 8.
8
Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.转甲状腺素蛋白与免疫球蛋白轻链淀粉样变患者的心房功能和几何结构差异:一项心脏磁共振研究。
Sci Rep. 2022 Jan 7;12(1):140. doi: 10.1038/s41598-021-03359-9.
9
Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.心脏磁共振和超声心动图检查发现的淀粉样变性所致的心脏结构和功能改变及其预后价值。
JACC Cardiovasc Imaging. 2019 May;12(5):823-833. doi: 10.1016/j.jcmg.2018.02.016. Epub 2018 Apr 18.
10
Mechanisms of heart failure in transthyretin vs. light chain amyloidosis.转甲状腺素蛋白与轻链淀粉样变性性心力衰竭的发病机制。
Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):512-524. doi: 10.1093/ehjci/jey225.

引用本文的文献

1
Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac Amyloidosis.肝细胞生长因子:心脏淀粉样变性中的心功能、死亡率及疾病亚型标志物
JACC Adv. 2025 May 30;4(6 Pt 1):101828. doi: 10.1016/j.jacadv.2025.101828.
2
Examining the Difficulties in Identifying and Handling Cardiac Amyloidosis; Acquiring Important Knowledge and Robust Treatment Methods.探讨识别和处理心脏淀粉样变性的难点;获取重要知识和稳健的治疗方法。
Cardiovasc Hematol Disord Drug Targets. 2024;24(2):65-82. doi: 10.2174/011871529X301954240715041558.
3
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy.
遗传性转甲状腺素蛋白淀粉样变性:一项以周围神经病变为重点的综述
Front Neurol. 2023 Oct 5;14:1242815. doi: 10.3389/fneur.2023.1242815. eCollection 2023.
4
The short and long-term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy.心脏闪烁照相术有 1 级心肌摄取的患者的短期和长期特征及结果。
ESC Heart Fail. 2023 Jun;10(3):1666-1676. doi: 10.1002/ehf2.14312. Epub 2023 Feb 17.
5
External Validation of the Kumamoto Criteria in Transthyretin Amyloid Cardiomyopathy Screening - A Retrospective Cohort Study.熊本标准在转甲状腺素蛋白淀粉样心肌病筛查中的外部验证——一项回顾性队列研究
Circ Rep. 2022 Nov 26;4(12):579-587. doi: 10.1253/circrep.CR-22-0110. eCollection 2022 Dec 9.
6
Coefficient of R-R interval variations under deep breathing load in patients with wild-type transthyretin amyloid cardiomyopathy: A case-control study.野生型转甲状腺素蛋白淀粉样心肌病患者深呼吸负荷下R-R间期变异性系数:一项病例对照研究。
Health Sci Rep. 2022 Nov 30;6(1):e938. doi: 10.1002/hsr2.938. eCollection 2023 Jan.
7
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis.转甲状腺素蛋白心脏淀粉样变的超声心动图参数进展与预后。
Eur J Heart Fail. 2022 Sep;24(9):1700-1712. doi: 10.1002/ejhf.2606. Epub 2022 Jul 27.
8
Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis.心脏淀粉样变性评估与预后的多模态成像
Front Cardiovasc Med. 2022 Mar 24;9:787618. doi: 10.3389/fcvm.2022.787618. eCollection 2022.
9
Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy.心力衰竭中心脏形态和功能的疾病进展:ATTR 心脏淀粉样变性与高血压性左心室肥厚。
Heart Vessels. 2022 Sep;37(9):1562-1569. doi: 10.1007/s00380-022-02048-5. Epub 2022 Mar 11.
10
Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.经导管主动脉瓣置换术后患者的转甲状腺素蛋白心脏淀粉样变性:临床和超声心动图表现及长期生存。
ESC Heart Fail. 2021 Dec;8(6):4549-4561. doi: 10.1002/ehf2.13667. Epub 2021 Oct 26.